RxDoctor Payments Data

David Sullivan

Internal Medicine · Madison, MSNPI 1386751329

Payments from drug & device makers

$5,738in general payments, 2019–2025

Across 364 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$862
  • Novo Nordisk$731
  • Pfizer$548
  • Lilly USA, LLC$401
  • Amgen$362
  • AstraZeneca$357
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$5,738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,738 in reported general payments places this provider in the 90th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$47,421
OzempicSemaglutide41$37,964
FarxigaDapagliflozin Propanediol31$29,552
JardianceEmpagliflozin26$25,369
TrulicityDulaglutide11$17,676
EntrestoSacubitril/Valsartan15$10,492
MyrbetriqMirabegron12$8,334
SynthroidLevothyroxine Sodium33$2,742
Sucralfate13$1,842
Metoprolol Succinate149$1,597
Ezetimibe54$1,437
Atorvastatin Calcium187$1,328
Potassium Chloride72$1,069
Pantoprazole Sodium108$1,018
Levothyroxine Sodium105$949

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$548$47,42164 claims
Novo NordiskOzempic$731$37,96441 claims
AstraZenecaFarxiga$357$29,55231 claims
Boehringer IngelheimJardiance$142$25,36926 claims
Lilly USA, LLCTrulicity$401$17,67611 claims
NovartisEntresto$191$10,49215 claims
Astellas Pharma US IncMyrbetriq$113$8,33412 claims
AbbVieSynthroid$862$2,74233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Madison

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →